Primus In News
Push for health care: BCD exemption for lifesaving drugs, additional medical seats and more in Budget 2025
01-02-2025
Nilaya Varma, Co-Founder and CEO, Primus Partners, stated that the government's move to reduce customs duties on life-saving drugs is a much-needed measure to help the middle class access critical treatments for life-threatening conditions.
Explore Related Insights
- India’s EV Ambitions Face Rare Earth Magnet Bottleneck, Report Urges Urgent Localisation | Report
- Covid-19: Assocham suggests war-footing steps; seeks moratorium on all debt repayments – Times of India
- Lasik surgery market to double by 2030 amid rising myopia, tech advances
- Powering ahead with caution: Tamil Nadu's offshore wind plan and its ripple effect on fisherman
